The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE: AstraZeneca jab rollout to resume in Ireland

Fri, 19th Mar 2021 20:44

(Alliance News) - The resumption of the rollout of the AstraZeneca PLC coronavirus vaccine has been recommended in Ireland.

Deputy Chief Medical Officer Ronan Glynn said he came to his decision following assessments of the jab by the European Medicines Agency and Ireland's National Immunisation Advisory Committee.

Glynn said Ireland's Health Minister Stephen Donnelly had accepted his recommendation.

He told a press conference on Friday evening that the Health Service Executive was meeting as he was speaking about resuming the use of AstraZeneca's vaccine in Ireland.

Glynn said more than 117,000 doses of the AstraZeneca vaccine had been administered in Ireland before the pause last Sunday due to concerns raised over clotting.

He said to date there had been no reports of serious clotting events associated with low platelets received by the Health Products Regulatory Authority in Ireland.

"People should be reassured that we acted quickly. We saw a signal, we acted upon it, counterparts across the EU acted upon it. They undertook an urgent investigation. They have looked at all the data and they have concluded it is safe to recommence the programme," he said.

"I would urge anyone now who is offered the vaccine to take it.

"We know that it is an extremely effective vaccine. We have seen the phenomenal effects that it is having on caseloads in other jurisdictions and we're lucky to have it as part of a range of vaccines that are now available to us."

Earlier, Taoiseach Micheal Martin said he would have no issue taking the AstraZeneca Covid-19 vaccine if he was offered it.

He also said the government was "gearing up" to resume administering the jab after its use was temporarily suspended in Ireland "in an abundance of caution" over the raising of concerns around blood clots.

Martin was speaking at the Port of Cork on Friday as he announced EUR405 million of funding for regeneration projects in Cork city and county.

Asked whether he would take the AstraZeneca vaccine, Martin said: "Yes I would. I would indeed.

"I expect a decision will be made today in relation to that. We're gearing up in terms of resuming that."

Glynn said on Thursday that he welcomed the EMA making its position clear and that the Niac was meeting with counterparts across Europe following the EMA's statement.

Glynn also indicated on Thursday that tough restrictions could remain in place until June.

Speaking on Friday, the Taoiseach said he would not speculate about changes to the public health restrictions for April and that the government would inform the public in the next couple of weeks of any changes to the measures.

"I am not going to speculate but we will give people clear indications in advance of April 5 as to how we see April panning out," Mr Martin said.

"I don't believe in speculating beyond that and we will certainly make it very clear to people.

"We are thinking and reflecting on the outdoor situation and outdoor activities and what might be possible there because mental health is very important."

He added: "We do understand and get it that people are fed up.

"I want to thank people; I think people have been remarkable. We have brought numbers down from a very high level after Christmas to very, relatively low levels. They're still high.

"Our big concern is the variant. This variant is more transmissible."

The deaths of a further 10 people with Covid-19 and another 507 cases were announced on Friday.

As of 8am, there were 336 Covid-positive patients in hospital, of whom 87 were in ICU.

As of March 16, 632,359 doses of the vaccine had been administered in Ireland.

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.